Skip to content
Screener

AbbVie ABBV Total costs & expenses

Total costs & expenses at other companies

Amgen logo
AmgenAMGN
$6.54B+0.3%
Incyte logo
IncyteINCY
$976.14M+42.5%
Bausch Health Companies logo
Bausch Health CompaniesBHC
$3.47B+75.2%
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
$31.52M+63.2%
Evolus logo
EvolusEOLS
$61.72M+11.2%
Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX

Other financials

Income statement

See full
Revenue$17.0B+10.2%
Gross profit$12.7B+14.6%
Operating income$6.4B+31.4%
Net income$3.6B+285%
EPS (diluted)$2.03+290%

Balance sheet

See full
Cash & equivalents$9.4B+81.5%
Total debt$62.4B+1.8%
Total equity-$6.7B-569%
Total assets$136.46B+0.2%

Cash flow

See full
Operating cash flow$3.8B+134%
CapEx$265.0M+12.8%
Free cash flow$3.6B+155%

Valuation

See full
Market cap$435.06B+25.5%
P/E69×-23.2×
P/S6.8×+0.8×

Profitability

See full
Gross margin71.5%+0.5pp
Operating margin26.2%
Net margin9.8%+3.3pp
FCF margin31.8%+5.0pp

Returns & leverage

See full
Return on equity89%+32.7pp
Debt / equity46.6×+38.6×
Current ratio0.8×0.0×

Where this comes from

Reported directly by AbbVie in its filing.

Tagged under the XBRL concept us-gaap:CostsAndExpenses.

The source filing: AbbVie’s 8-K, filed July 31, 2026. Open the filing →

Filed
Jul 31, 2026, 7:51 AM EDT
Accession
0001551152-26-000023

FAQ

What is AbbVie's total costs & expenses?
AbbVie (ABBV) reported total costs & expenses of $10.56B in Q2 2026.
How has AbbVie's total costs & expenses changed year-over-year?
AbbVie's total costs & expenses increased by 0.3% year-over-year, from $10.53B to $10.56B.
What is the long-term trend for AbbVie's total costs & expenses?
Over 4 years (2021 to 2025), AbbVie's total costs & expenses has grown at a 4.8% compound annual growth rate (CAGR), from $38.27B to $46.09B.

Ask your AI about AbbVie's total costs & expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude